MyFinsight
Home
Blog
About
Contact
Download
Download image
something is missing
$493,250
Fda clinical trial
expenses paid directly by...
$244,783
Contribution of capital
$86,307
Net cash provided by
financing activities
$824,340
Net increase
(decrease) in cash
$1,234
Canceled cashflow
$823,106
Accounts payable
$21,158
Prepaids
-$300
Net cash used by
operating activities
-$823,106
Canceled cashflow
$21,458
something is missing
-$493,250
Net loss
-$328,862
Accrued liabilities
-$22,452
Back
Back
Cash Flow
source: myfinsight.com
BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
BURZYNSKI RESEARCH INSTITUTE INC (BZYR)